Tranexamic Acid in Patients for Caesarian Delivery. (TXA; CD)
Postpartum Hemorrhage, Cesarean Section Complications, Obstetric Anesthesia Problems
About this trial
This is an interventional other trial for Postpartum Hemorrhage focused on measuring caesarian delivery, postpartum haemorrhage, obstetrics quality of recovery, tranexamic acid
Eligibility Criteria
Inclusion Criteria: The inclusion criteria will include: Informed consent of the participant All women who are 18 years old or above Gestational age equal or above 34 weeks Women undergoing emergency or elective CD Complete blood count (CBC) within seven days before the CD Exclusion Criteria: The exclusion criteria will include: Women with thromboembolic or bleeding incidents in the past Hypersensitivity to TXA History of epilepsy or seizure Women with abnormal placenta including accreta, increta or percreta Any active cardiovascular, renal, or liver disorders Autoimmune disorders Sickle cell disease Placenta Previa Abruptio Placentae Eclampsia or HELLP syndrome Women who might undergo intraoperative complications.
Sites / Locations
- DowUHSRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Tranexamic Acid
Normal Saline